Shares of Moderna are trading lower Friday morning after the company announced official terms for a major private debt offering.

Shares of Moderna are trading higher Tuesday morning, as Wall Street analysts upgrade their ratings following landmark Phase 3 oncology data.

Moderna shares are trading lower Wednesday morning, pausing after a 150% surge on landmark clinical trial updates for its oncology pipeline.